Stephen T Furlong

Title: Innovations by Stephen T. Furlong

Introduction

Stephen T. Furlong is an accomplished inventor based in Wilmington, Delaware. He has made significant contributions to the field of immunology, particularly in the presentation of hydrophobic antigens to T-cells. With a total of two patents to his name, Furlong's work has implications for vaccine development and immune response modulation.

Latest Patents

Furlong's latest patents focus on the presentation of hydrophobic antigens to T-cells by CD1 molecules. These patents provide a comprehensive overview of CD1-presented antigens, including compositions, cells, inhibitors, and methods related to hydrophobic antigen presentation. The patents detail methods for detecting the presence of CD1-presented hydrophobic antigens in samples, isolating such antigens, and developing vaccines that incorporate these antigens. Additionally, they outline methods for blocking CD1 antigen presentation and identifying CD1 blocking agents, as well as methods for inducing CD1 expression.

Career Highlights

Stephen T. Furlong is affiliated with The Brigham and Women's Hospital, Inc., where he continues to advance research in immunology. His work has garnered attention for its potential to enhance vaccine efficacy and improve immune responses.

Collaborations

Furlong has collaborated with notable colleagues, including Steven A. Porcelli and Michael B. Brenner, contributing to a rich environment of innovation and research in his field.

Conclusion

Stephen T. Furlong's contributions to the field of immunology through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in vaccine development and immune system understanding.